<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0">
<channel>
<title>Beijing Beilu Pharmaceutical Co., Ltd. Latest Press Releases</title>
<link>https://pressroom.prlog.org/BeiluPharmaceutical/</link>
<description>About Beijing Beilu Pharmaceutical Co., Ltd. - Beilu Pharma is a leader and pioneer in the Contrast Media field in China. It provides a wide range of Contrast Media products for diagnostic imaging and interventional therapy, and it also offers Anti-diabetic and Anti-anxiety medicines.</description>
<item><title>[New Product] Beilu Pharma's Vonoprazan Fumarate Tablets Received Approval</title>
<link>https://www.prlog.org/13157848-new-product-beilu-pharmas-vonoprazan-fumarate-tablets-received-approval.html</link>
<description>Recently, Beilu Pharma received the &quot;Drug Registration Certificate&quot; for its Vonoprazan Fumarate Tablets, approved and issued by the National Medical Products Administration (NMPA).</description><pubDate>Mon, 13 Jul 2026 07:02:23 GMT</pubDate></item>
<item><title>Iohexol Injection of Beilu Pharmaceutical Receives MA in the EU</title>
<link>https://www.prlog.org/13071668-iohexol-injection-of-beilu-pharmaceutical-receives-ma-in-the-eu.html</link>
<description>Recently, Beijing Beilu Pharmaceutical Co., Ltd. received the &quot;Marketing Authorization&quot; (MA) issued by the Netherlands Medicines Evaluation Board (MEB) in accordance with the relevant regulations of the European Medicines Agency.</description><pubDate>Thu, 17 Apr 2025 03:19:30 GMT</pubDate></item>
</channel>
</rss>